Get the Stockscreener App
2.08
0.48%
0.01
After Hours:
2.09
0.010
+0.48%
Seer Inc stock is traded at $2.08, with a volume of 143.27K.
It is up +0.48% in the last 24 hours and down -5.88% over the past month.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.
See More
Previous Close:
$2.07
Open:
$2.1
24h Volume:
143.27K
Relative Volume:
1.20
Market Cap:
$108.77M
Revenue:
$14.18M
Net Income/Loss:
$-82.66M
P/E Ratio:
-1.60
EPS:
-1.3
Net Cash Flow:
$-50.80M
1W Performance:
-4.15%
1M Performance:
-5.88%
6M Performance:
+10.05%
1Y Performance:
-7.96%
1-Day Range:
$2.05
$2.11
1-Week Range:
$2.045
$2.17
52-Week Range:
$1.62
$2.625
Seer Inc Stock (SEER) Company Profile
Name
Seer Inc
Sector
Industry
Phone
650-453-0000
Address
3800 BRIDGE PARKWAY, SUITE 102, REDWOOD CITY
Compare SEER with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SEER
Seer Inc
|
2.08 | 116.60M | 14.18M | -82.66M | -50.80M | -1.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
434.19 | 106.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
681.72 | 68.81B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.74 | 58.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
889.89 | 53.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
377.47 | 36.43B | 4.56B | -176.77M | 225.30M | -1.7177 |
Seer Inc Stock (SEER) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-05-23 | Resumed | JP Morgan | Neutral |
| Jan-04-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Aug-11-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Dec-29-20 | Initiated | BofA Securities | Neutral |
| Dec-29-20 | Initiated | Cowen | Outperform |
| Dec-29-20 | Initiated | JP Morgan | Overweight |
| Dec-29-20 | Initiated | Morgan Stanley | Equal-Weight |
View All
Seer Inc Stock (SEER) Latest News
Custom strategy builders for tracking Seer Inc.2025 Performance Recap & Detailed Earnings Play Strategies - newser.com
Volatility clustering patterns for Seer Inc.Quarterly Earnings Summary & Daily Technical Forecast Reports - newser.com
How to manage a losing position in Seer Inc.2025 Major Catalysts & Free Growth Oriented Trading Recommendations - newser.com
How to forecast Seer Inc. trends using time seriesMarket Performance Summary & Verified Chart Pattern Trade Signals - newser.com
Is Seer Inc. stock a smart buy before Fed meetingDollar Strength & Growth Focused Investment Plans - newser.com
How Seer Inc. stock performs in stagflationJuly 2025 Selloffs & Risk Controlled Daily Plans - newser.com
Seer, Inc. Earnings Call: Achievements Amid Challenges - TipRanks
Key metrics from Seer Inc.’s quarterly dataJuly 2025 Gainers & Community Supported Trade Ideas - newser.com
Why Seer Inc. stock is rated strong buyMarket Performance Report & Precise Buy Zone Tips - newser.com
Seer Trims Losses On Strong Demand For Proteograph ONE - Finimize
Seer, Inc. (NASDAQ:SEER) Q3 2025 Earnings Call Transcript - Insider Monkey
TD Cowen Maintains Seer Inc(SEER.US) With Buy Rating - 富途牛牛
Seer expects 2025 revenue at lower end of $17M–$18M range amid persistent funding headwinds - MSN
Seer, Inc. and Collaborators Unveil Broad New Data Demonstrating the Translational Power of Deep Proteomics at HUPO 2025 - MarketScreener
Seer and Collaborators Unveil Broad New Data Demonstrating the Translational Power of Deep Proteomics at HUPO 2025 - The Manila Times
16 posters, 2 invited talks spotlight Seer (NASDAQ: SEER) deep proteomics at HUPO - Stock Titan
Seer, Inc. Reports Modest Revenue Growth in Q3 2025 - TipRanks
Seer Inc (SEER) Q3 2025 Earnings Call Highlights: Navigating Cha - GuruFocus
Seer Inc reports results for the quarter ended September 30Earnings Summary - TradingView
Seer Q3 2025 slides: modest revenue growth amid strategic repositioning By Investing.com - Investing.com South Africa
Seer : Q3 2025 Earnings Presentation - MarketScreener
Life sciences company Seer's Q3 net loss narrows - MarketScreener
Seer Inc (SEER) Q3 2025 Earnings: EPS Misses at -$0.32, Revenue Surpasses at $4.1 Million - GuruFocus
[10-Q] Seer, Inc. Quarterly Earnings Report | SEER SEC FilingForm 10-Q - Stock Titan
Seer, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
Seer, Inc. (SEER) Q3 FY2025 earnings call transcript - Yahoo Finance
[8-K] Seer, Inc. Reports Material Event | SEER SEC FilingForm 8-K - Stock Titan
Seer Reports Third Quarter 2025 Financial Results - The Manila Times
Seer, Inc. Reports Third Quarter 2025 Financial Results Highlighting Revenue Growth and Increased Instrument Shipments - Quiver Quantitative
Does Seer Inc. stock trade at a discount to peersJuly 2025 Fed Impact & Fast Exit Strategy with Risk Control - newser.com
Is Seer Inc. stock supported by strong fundamentalsMarket Performance Report & Target Return Focused Stock Picks - fcp.pa.gov.br
Is Seer Inc. trending in predictive chart models2025 Stock Rankings & Expert Curated Trade Setups - newser.com
Why Seer Inc. stock is seen as undervaluedJuly 2025 Fed Impact & Advanced Technical Signal Analysis - newser.com
Does Seer Inc. qualify in momentum factor screening2025 Earnings Impact & Community Verified Swing Trade Signals - newser.com
Seer Inc Stock (SEER) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.62%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):